ATC code L
From Infogalactic: the planetary knowledge core
Jump to: navigation, search
ATC code L Antineoplastic and immunomodulating agents is a section of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products.[1]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QL.[2]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
| L Antineoplastic and immunomodulating agents |
|---|
| L01 Antineoplastic agents |
| L02 Endocrine therapy |
| L03 Immunostimulants |
| L04 Immunosuppressants |
|
|
References
| Gastrointestinal tract/ metabolism (A) |
|
|---|---|
| Blood and blood forming organs (B) |
|
| Cardiovascular system (C) |
|
| Skin (D) | |
| Genitourinary system (G) |
|
| Endocrine system (H) |
|
| Infections and infestations (J, P, QI) |
|
| Malignant disease (L01-L02) |
|
| Immune disease (L03-L04) |
|
| Muscles, bones, and joints (M) |
|
| Brain and nervous system (N) |
|
| Respiratory system (R) |
|
| Sensory organs (S) | |
| Other ATC (V) | |
| SPs/MIs (M phase) |
|
||||||||
|---|---|---|---|---|---|---|---|---|---|
| DNA replication inhibitor |
|||||||||
| Photosensitizers/PDT | |||||||||
| Other |
|
||||||||
|
|||||||||
| CI monoclonal antibodies ("-mab") |
|
||||||
|---|---|---|---|---|---|---|---|
| Tyrosine-kinase inhibitors ("-nib") |
|
||||||
| Other |
|
||||||
| Endogenous |
|
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Exogenous | |||||||||||||
| Intracellular (initiation) |
|
||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intracellular (reception) |
|
||||||||||||||
| Extracellular |
|
||||||||||||||
|
|||||||||||||||
Retrieved from "https://infogalactic.com/w/index.php?title=ATC_code_L&oldid=1653067"
